Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04881149 · ClinicalTrials.gov registry record · NA
Rollover Study to Evaluate Histological Results of Radiofrequency Device Treatments on the Flanks
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04881149: Completed NA study, sponsored by Cynosure.
NCT04881149 is a NA study that has completed, run by Cynosure. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04881149, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate histological results of the treatments with the TempSure Firm handpiece on the flanks performed in the CYN20-FIRM-LIPO study.
Primary Outcome
Sections of skin were removed using the punch biopsy technique to render a microscopic diagnosis. Each specimen was preserved with a fixative and then stained using Hemotoxylin \& Eosin, Verhoeff and Masson Red/Fast Green and/or nitroblue tetrazolium chloride (NBTC) staining methods. If using Hemotoxylin \& Eosin, Verhoeff and Masson Red/Fast Green staining, samples were assessed and evaluated by the amount of elastin. If using NBTC staining, samples were assessed and evaluated to differentiate
Interventions
- DEVICE TempSure treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-02-12 |
| Est. Completion | 2021-03-10 |
| Phase | NA |
What the finished NCT04881149 record still lists
NCT04881149 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which TempSure treatment is the first listed.
NCT04881149 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04881149 about?
NCT04881149 is a clinical study titled "Rollover Study to Evaluate Histological Results of Radiofrequency Device Treatments on the Flanks". The purpose of this study is to evaluate histological results of the treatments with the TempSure Firm handpiece on the flanks performed in the CYN20-FIRM-LIPO study.
What is the current status of trial NCT04881149?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2021-02-12. Estimated completion is 2021-03-10.
What interventions are being tested in trial NCT04881149?
The interventions under investigation include: TempSure treatment (DEVICE).
Who is sponsoring clinical trial NCT04881149?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04881149's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI